EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Noninvasive, microbiome-based diagnosis of inflammatory bowel disease

Jiaying Zheng, Qianru Sun, Mengjing Zhang, Chengyu Liu, Qi Su, Lin Zhang, Zhilu Xu, Wenqi Lu, Jessica Ching, Whitney Tang, Chun Pan Cheung, Amy L Hamilton und 10 weitere

Nature Medicine · 2024-12 · 30 (12) · 3555-3567

DOI: 10.1038/s41591-024-03280-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Medicine, online erschienen am 04.10.2024. Verfasst von Jiaying Zheng und 21 weiteren Autor:innen. Beteiligte Einrichtung: Microbiota I-Center (MagIC), Hong Kong, China. Hauptthemen laut MEDLINE: Feces, Inflammatory Bowel Diseases, Crohn Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 156-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Research Grants Council, University Grants Committee (RGC, UGC), Leona M. and Harry B. Helmsley Charitable Trust (Helmsley Charitable Trust), Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (HMRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite recent progress in our understanding of the association between the gut microbiome and inflammatory bowel disease (IBD), the role of microbiome biomarkers in IBD diagnosis remains underexplored. Here we developed a microbiome-based diagnostic test for IBD. By utilization of metagenomic data from 5,979 fecal samples with and without IBD from different geographies and ethnicities, we identified microbiota alterations in IBD and selected ten and nine bacterial species for construction of diagnostic models for ulcerative colitis and Crohn's disease, respectively. These diagnostic models achieved areas under the curve >0.90 for distinguishing IBD from controls in the discovery cohort, and maintained satisfactory performance in transethnic validation cohorts from eight populations. We further developed a multiplex droplet digital polymerase chain reaction test targeting selected IBD-associated bacterial species, and models based on this test showed numerically higher performance than fecal calprotectin in discriminating ulcerative colitis and Crohn's disease from controls. Here we discovered universal IBD-associated bacteria and show the potential applicability of a multibacteria biomarker panel as a noninvasive tool for IBD diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesInflammatory Bowel DiseasesCrohn DiseaseGastrointestinal MicrobiomeBiomarkersColitis, UlcerativeHumansFemaleMaleAdultLeukocyte L1 Antigen ComplexBacteriaMetagenomicsMiddle AgedCase-Control StudiesMicrobiota

Substanzen

BiomarkersLeukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Microbiota I-Center (MagIC), Hong Kong, China.
  • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.
  • Department of Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Förderung

  • Research Grants Council, University Grants Committee (RGC, UGC)
  • Leona M. and Harry B. Helmsley Charitable Trust (Helmsley Charitable Trust)
  • Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (HMRF)
  • National Natural Science Foundation of China (National Science Foundation of China)

Zitieren

APA

Zheng, J., Sun, Q., Zhang, M., Liu, C., Su, Q., Zhang, L., Xu, Z., Lu, W., Ching, J., Tang, W., Cheung, C. P., Hamilton, A. L., Wilson O'Brien, A. L., Wei, S. C., Bernstein, C. N., Rubin, D. T., Chang, E. B., Morrison, M., Kamm, M. A., …, & Ng, S. C. (2024). Noninvasive, microbiome-based diagnosis of inflammatory bowel disease. Nature Medicine, 30(12), 3555-3567. https://doi.org/10.1038/s41591-024-03280-4

Vancouver

Zheng J, Sun Q, Zhang M, Liu C, Su Q, Zhang L, et al. Noninvasive, microbiome-based diagnosis of inflammatory bowel disease. Nature Medicine. 2024;30(12):3555-3567. doi:10.1038/s41591-024-03280-4

BibTeX
@article{Zheng2024,
  author = {Zheng, Jiaying and Sun, Qianru and Zhang, Mengjing and Liu, Chengyu and Su, Qi and Zhang, Lin and Xu, Zhilu and Lu, Wenqi and Ching, Jessica and Tang, Whitney and Cheung, Chun Pan and Hamilton, Amy L and Wilson O'Brien, Amy L and Wei, Shu Chen and Bernstein, Charles N and Rubin, David T and Chang, Eugene B and Morrison, Mark and Kamm, Michael A and Chan, Francis K L and Zhang, Jingwan and Ng, Siew C},
  title = {Noninvasive, microbiome-based diagnosis of inflammatory bowel disease},
  journal = {Nature Medicine},
  year = {2024},
  volume = {30},
  number = {12},
  pages = {3555--3567},
  doi = {10.1038/s41591-024-03280-4}
}
Kostenlos starten →